share_log

HC Wainwright & Co. Maintains Buy on Aurinia Pharmaceuticals, Raises Price Target to $15

Benzinga ·  Aug 7, 2023 12:02

HC Wainwright & Co. analyst Ed Arce maintains Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Buy and raises the price target from $14 to $15.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment